Capstone Investment Advisors, LLC Biogen Inc. Put Options Transaction History

Capstone Investment Advisors, LLC

$30.4 Billion
Q3 2024

Put Options

26 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$189.07 - $236.8 $907,536 - $1.14 Million	4,800 Added 15.38%	36,000 $6.98 Million
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $3.52 Million - $4.38 Million	18,500 Added 145.67%	31,200 $7.23 Million
Q1 2024 May 01, 2024	SELL	$212.02 - $267.71 $2.99 Million - $3.77 Million	-14,100 Reduced 52.61%	12,700 $2.74 Million
Q4 2023 Feb 12, 2024	BUY	$222.59 - $267.94 $1.6 Million - $1.93 Million	7,200 Added 36.73%	26,800 $6.94 Million
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $379,950 - $428,835	1,500 Added 8.29%	19,600 $5.04 Million
Q2 2023 Aug 10, 2023	BUY	$275.25 - $318.06 $55,050 - $63,612	200 Added 1.12%	18,100 $5.16 Million
Q1 2023 May 09, 2023	SELL	$256.56 - $292.34 $1.69 Million - $1.93 Million	-6,600 Reduced 26.94%	17,900 $4.98 Million
Q4 2022 Feb 10, 2023	BUY	$252.44 - $306.72 $227,196 - $276,048	900 Added 3.81%	24,500 $6.78 Million
Q3 2022 Nov 10, 2022	BUY	$194.69 - $268.46 $292,035 - $402,689	1,500 Added 6.79%	23,600 $6.3 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $5.51 Million - $6.56 Million	-29,400 Reduced 57.09%	22,100 $4.51 Million
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $5.62 Million - $7.08 Million	-29,000 Reduced 36.02%	51,500 $10.8 Million
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $2.82 Million - $3.63 Million	-12,600 Reduced 13.53%	80,500 $19.3 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $6.71 Million - $8.75 Million	23,700 Added 34.15%	93,100 $26.3 Million
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $1.61 Million - $2.57 Million	-6,200 Reduced 8.2%	69,400 $24 Million
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $2.16 Million - $2.53 Million	8,900 Added 13.34%	75,600 $21.1 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $6.1 Million - $9.18 Million	-25,800 Reduced 27.89%	66,700 $16.3 Million
Q3 2020 Nov 16, 2020	BUY	$264.77 - $305.71 $9.72 Million - $11.2 Million	36,700 Added 65.77%	92,500 $26.2 Million
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $3.65 Million - $4.83 Million	14,100 Added 33.81%	55,800 $14.9 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $11.6 Million - $14.7 Million	-43,100 Reduced 50.83%	41,700 $13.2 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $396,108 - $547,326	1,800 Added 2.17%	84,800 $25.2 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $2.22 Million - $2.49 Million	10,200 Added 14.01%	83,000 $19.3 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $6.12 Million - $6.74 Million	27,900 Added 62.14%	72,800 $17 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $975,195 - $1.53 Million	4,500 Added 11.14%	44,900 $10.6 Million
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $2.51 Million - $3.17 Million	9,000 Added 28.66%	40,400 $12.2 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $6.43 Million - $8.41 Million	21,900 Added 230.53%	31,400 $11.1 Million
Q2 2018 Aug 13, 2018	BUY	$257.52 - $306.91 $2.45 Million - $2.92 Million	9,500 New	9,500 $2.76 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Account